| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |